Physicians recognized for their contributions to clinical research and advances in the treatment of people with Alzheimer's have called for immediate changes to how healthcare professionals approach the management of the disease.
Experts are gathering in Toronto for the Alzheimer’s Association International Conference and a number of them have cited statistics showing a lack of diagnosis and of use of currently available prescription medicines. They have called for better education of primary care doctors to eliminate misconceptions as a critical first step to give people with Alzheimer's a fighting chance.
The physicians have also emphasized that drugs affecting the cholinergic system are the only treatments shown to have a positive impact on all stages of the disease – something established by two decades of clinical trials and real world observational studies as well as new research.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze